Spatial and temporal stability of paneth cell phenotypes in crohn's disease: Implications for prognostic cellular biomarker development

Inflammatory Bowel Diseases

Volumn 20, Issue 4, 2014, Pages 646-651

  Liu, Ta Chiang ^a   Gao, Feng ^a   McGovern, Dermot P B ^b,c   Stappenbeck, Thaddeus S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b F Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Defensin; Endoscopy; Immunofluorescence; Lysozyme; Stratification

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BIOPSY; CELL STRUCTURE; CLINICAL ARTICLE; COLON BIOPSY; COLON SURGERY; CONTROLLED STUDY; CORRELATIONAL STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE DURATION; GENETIC STABILITY; HUMAN; HUMAN TISSUE; ILEUM RESECTION; INTESTINE CRYPT; LONGITUDINAL STUDY; PANETH CELL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; VIRTUAL BIOPSY; ILEUM; INTESTINE MUCOSA; PATHOLOGY; THEORETICAL MODEL; TIME;

BIOLOGICAL MARKERS; BIOPSY; CROHN DISEASE; HUMANS; ILEUM; INTESTINAL MUCOSA; MODELS, THEORETICAL; PANETH CELLS; PHENOTYPE; PROGNOSIS; TIME FACTORS;

EID: 84898712591     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000442838.21040.d7     Document Type: Article

References (15)

1. Virgin HW, Todd JA. Metagenomics and personalized medicine. Cell. 2011;147:44-56.
2. Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature. 2011;469:323-335.
3. Virgin HW, Levine B. Autophagy genes in immunity. Nat Immunol. 2009;10:461-470.
4. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119-124.
5. Meisch JP, Nishimura M, Vogel RM, et al. Human beta-defensin 3 peptide is increased and redistributed in Crohn's ileitis. Inflamm Bowel Dis. 2013;19:942-953.
6. Gunther C, Martini E, Wittkopf N, et al. Caspase-8 regulates TNFalpha- induced epithelial necroptosis and terminal ileitis. Nature. 2011; 477:335-339.
7. Cadwell K, Liu JY, Brown SL, et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature. 2008;456:259-263.
8. Cadwell K, Patel KK, Maloney NS, et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell. 2010;141:1135-1145.
9. VanDussen KL, Liu TC, Li D, et al. Genetic variants synthesize to produce Paneth cell phenotypes that define subtypes of Crohn's disease. Gastroenterology. 2014;146:200-209.
10. Baldassano RN, Bradfield JP, Monos DS, et al. Association of the T300A non-synonymous variant of the ATG16L1 gene with susceptibility to paediatric Crohn's disease. Gut. 2007;56:1171-1173.
11. Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet. 2001;357:1925-1928.
12. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucinerich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411:599-603.
13. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411: 603-606.
14. Homer CR, Richmond AL, Rebert NA, et al. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. Gastroenterology. 2010;139:1630-1641, 1641 e1631-1632.
15. Rickard DJ, Sehon CA, Kasparcova V, et al. Identification of benzimidazole diamides as selective inhibitors of the nucleotide-binding oligomerization domain 2 (NOD2) signaling pathway. PLoS One. 2013;8:e69619.